Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease - PubMed (original) (raw)
Review
Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease
Rodrigo A Fuentealba et al. Brain Res Brain Res Rev. 2004 Dec.
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder with progressive dementia accompanied by two main structural changes in the brain: intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular amyloid protein deposits surrounded by dystrophic neurites that constitutes the senile plaques. Currently, it is widely accepted that amyloid beta-peptide (A beta) metabolism disbalance is crucial for AD progression. A beta deposition may be enhanced by molecular chaperones, including metals like copper and proteins like acetylcholinesterase (AChE). At the neuronal level, several AD-related proteins interact with transducers of the Wnt/beta-catenin signaling pathway, including beta-catenin and glycogen synthase kinase 3 beta (GSK-3 beta) and both in vitro and in vivo studies suggest that Wnt/beta-catenin signaling is a target for A beta toxicity. Accordingly, activation of this signaling by lithium or Wnt ligands in AD-experimental animal models or in primary hippocampal neurons attenuate A beta neurotoxicity by recovering beta-catenin levels and Wnt-target gene expression of survival genes such as bcl-2. On the other hand, peroxisomal proliferator-activated receptor gamma (PPAR gamma) and muscarinic acetylcholine receptor (mAChR) agonists also activate Wnt/beta-catenin signaling and they have neuroprotective effects on hippocampal neurons. Our studies are consistent with the idea that a sustained loss of function of Wnt signaling components would trigger a series of events, determining the onset and development of AD and that modulation of this pathway through the activation of cross-talking signaling cascades should be considered as a possible therapeutic strategy for AD treatment.
Similar articles
- Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
De Ferrari GV, Chacón MA, Barría MI, Garrido JL, Godoy JA, Olivares G, Reyes AE, Alvarez A, Bronfman M, Inestrosa NC. De Ferrari GV, et al. Mol Psychiatry. 2003 Feb;8(2):195-208. doi: 10.1038/sj.mp.4001208. Mol Psychiatry. 2003. PMID: 12610652 - Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling.
Inestrosa NC, Godoy JA, Quintanilla RA, Koenig CS, Bronfman M. Inestrosa NC, et al. Exp Cell Res. 2005 Mar 10;304(1):91-104. doi: 10.1016/j.yexcr.2004.09.032. Epub 2004 Dec 10. Exp Cell Res. 2005. PMID: 15707577 - Wnt signaling in Alzheimer's disease: up or down, that is the question.
Boonen RA, van Tijn P, Zivkovic D. Boonen RA, et al. Ageing Res Rev. 2009 Apr;8(2):71-82. doi: 10.1016/j.arr.2008.11.003. Epub 2008 Dec 3. Ageing Res Rev. 2009. PMID: 19101658 Review. - Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway.
Arrázola MS, Varela-Nallar L, Colombres M, Toledo EM, Cruzat F, Pavez L, Assar R, Aravena A, González M, Montecino M, Maass A, Martínez S, Inestrosa NC. Arrázola MS, et al. J Cell Physiol. 2009 Dec;221(3):658-67. doi: 10.1002/jcp.21902. J Cell Physiol. 2009. PMID: 19711354 - The role of Wnt signaling in neuroprotection.
Cerpa W, Toledo EM, Varela-Nallar L, Inestrosa NC. Cerpa W, et al. Drug News Perspect. 2009 Dec;22(10):579-91. doi: 10.1358/dnp.2009.10.1436817. Drug News Perspect. 2009. PMID: 20140278 Review.
Cited by
- Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons.
Podvin S, Jones A, Liu Q, Aulston B, Mosier C, Ames J, Winston C, Lietz CB, Jiang Z, O'Donoghue AJ, Ikezu T, Rissman RA, Yuan SH, Hook V. Podvin S, et al. ACS Omega. 2021 May 13;6(20):13033-13056. doi: 10.1021/acsomega.1c00660. eCollection 2021 May 25. ACS Omega. 2021. PMID: 34056454 Free PMC article. - Resveratrol Mediated Regulation of Hippocampal Neuroregenerative Plasticity via SIRT1 Pathway in Synergy with Wnt Signaling: Neurotherapeutic Implications to Mitigate Memory Loss in Alzheimer's Disease.
Surya K, Manickam N, Jayachandran KS, Kandasamy M, Anusuyadevi M. Surya K, et al. J Alzheimers Dis. 2023;94(s1):S125-S140. doi: 10.3233/JAD-220559. J Alzheimers Dis. 2023. PMID: 36463442 Free PMC article. Review. - Lipid-induced beta-amyloid peptide assemblage fragmentation.
Widenbrant MJ, Rajadas J, Sutardja C, Fuller GG. Widenbrant MJ, et al. Biophys J. 2006 Dec 1;91(11):4071-80. doi: 10.1529/biophysj.106.085944. Biophys J. 2006. PMID: 17098805 Free PMC article. - Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling.
Magdesian MH, Carvalho MM, Mendes FA, Saraiva LM, Juliano MA, Juliano L, Garcia-Abreu J, Ferreira ST. Magdesian MH, et al. J Biol Chem. 2008 Apr 4;283(14):9359-68. doi: 10.1074/jbc.M707108200. Epub 2008 Jan 30. J Biol Chem. 2008. PMID: 18234671 Free PMC article. - Serum Homocysteine and Behavioral and Psychological Symptoms of Dementia: Is There Any Correlation in Alzheimer's Disease?
Soni RM, Tiwari SC, Mahdi AA, Kohli N. Soni RM, et al. Ann Neurosci. 2019 Jan;25(3):152-159. doi: 10.1159/000487068. Epub 2018 May 30. Ann Neurosci. 2019. PMID: 30814822 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous